Effects of low doses of bisphenol a on the metabolome of perinatally exposed CD-1 mice

Environmental Health Perspectives

Volumn 121, Issue 5, 2013, Pages 586-593

  Cabaton, Nicolas J ^a,b   Canlet, Cécile ^a,b   Wadia, Perinaaz R ^c   Tremblay Franco, Marie ^a,b   Gautier, Roselyne ^a,b   Molina, Jérôme ^a,b   Sonnenschein, Carlos ^c   Cravedi, Jean Pierre ^a,b   Rubin, Beverly S ^c   Soto, Ana M ^c   Zalko, Daniel ^a,b  

^a CEMAGREF   (France)

^b TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bisphenol A; Endocrine disruptor; Fetal origins of adult disease; Low dose; Metabo lomics; Metabonomics; NMR fingerprints; Partial least squares discriminant analysis (PLS DA); Perinatal exposure; Toxicology

Indexed keywords

4 AMINOBUTYRIC ACID; 4, 4' ISOPROPYLIDENEDIPHENOL; AMINO ACID; ENDOCRINE DISRUPTOR; GLUCOSE; GLUTAMIC ACID; GLUTATHIONE; PYRUVIC ACID; TAURINE; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; ENERGY METABOLISM; ENVIRONMENTAL EXPOSURE; FEMALE; FINGER DERMATOGLYPHICS; FOURIER TRANSFORMATION; IN VIVO STUDY; MALE; METABOLOME; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OSMOTIC PUMP; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL;

ANIMALS; BENZHYDRYL COMPOUNDS; ENDOCRINE DISRUPTORS; FEMALE; FETUS; LACTIC ACID; LIVER; MALE; METABOLOME; MICE; PHENOLS; PREGNANCY;

ANIMALIA; MUS; RODENTIA;

EID: 84877081475     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1205588     Document Type: Article

References (54)

1. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. 2006. The estrogenic effect of bisphenol A disrupts pancreatic β-cell function in vivo and induces insulin resistance. Environ Health Perspect 114:106-112.
2. Alonso-Magdalena P, Ropero AB, Soriano S, García-Arévalo M, Ripoll C, Fuentes E, etal. 2012. Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways. Mol Cel Endocrinol 355:201-207.
3. Alonso-Magdalena P, Vieira E, Soriano S, Menes L, Burks D, Quesada I, etal. 2010. Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environ Health Perspect 118:1243-1250.
4. Asimakopoulos AG, Thomaidis NS, Koupparis MA. 2012. Recent trends in biomonitoring of bisphenol A, 4-t-octylphenol, and 4-nonylphenol. Toxicol Lett 210:141-154.
5. Barker DJ. 2004. The developmental origins of adult disease. J Am Coll Nutr 23:588S-595S.
6. Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, et al. 2000. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol Sci 54:138-153.
7. Cabaton NJ, Wadia PR, Rubin BS, Zalko D, Schaeberle CM, Askenase MH, etal. 2011. Perinatal exposure to environmentally relevant levels of bisphenol A decreases fertility and fecundity in CD-1 mice. Environ Health Perspect 119:547-552.
8. Calafat AM, Weuve J, Ye X, Jia LT, Hu H, Ringer S, etal. 2009. Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect 117:639-644.
9. Calafat AM, Ye X, Silva MJ, Kuklenyik Z, Needham LL. 2006. Human exposure assessment to environmental chemicals using biomonitoring. Int J Androl 29:166-171.
10. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. 2008. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 116:39-44.
11. Coe BL, Kirkpatrick JR, Taylor JA, Vom Saal FS. 2008. A new 'crowded uterine horn' mouse model for examining the relationship between foetal growth and adult obesity. Basic Clin Pharmacol Toxicol 102:162-167.
12. Coen M. 2010. A metabonomic approach for mechanistic exploration of pre-clinical toxicology. Toxicology 278:326-340.
13. European Commission. 2011. Commission Directive 2011/8/EU, amending Directive 2002/72/EC as regards the restriction of use of bisphenol A in plastic infant feeding bottles. Off J Eur Union L26:11-14. Available: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:026:0011:0014:EN:PDF [accessed 4March 2013].
14. European Food Safety Authority. 2006. Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food on a request from the commission related to 2,2-bis(4-hydroxyphenyl)propane (bisphenol A). EFSAJ 428:1-75. Available: http://www.efsa.europa.eu/de/scdocs/doc/428.pdf [accessed 28 February 2013].
15. Fernandez MF, Arrebola JP, Taoufiki J, Navalón A, Ballesteros O, Pulgar R, etal. 2007. Bisphenol-A and chlorinated derivatives in adipose tissue of women. Reprod Toxicol 24:259-264.
16. Folch J, Ascoli I, Lees M, Meath JA, Le BN. 1951. Preparation of lipid extracts from brain tissue. J Biol Chem 191:833-841.
17. Gavaghan CL, Wilson ID, Nicholson JK. 2002. Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA. FEBS Lett 530:191-196.
18. Goodson A, Robin H, Summerfield W, Cooper I. 2004. Migration of bisphenol A from can coatings-effects of damage, storage conditions and heating. Food Addit Contam 21:1015-1026.
19. Heindel JJ, vom Saal FS. 2009. Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Mol Cell Endocrinol 304:90-96.
20. Ishido M, Masuo Y, Terasaki M, Morita M. 2011. Rat hyperactivity by bisphenol A, but not by its derivatives, 3-hydroxybisphenol A or bisphenol A 3,4-quinone. Toxicol Lett 206:300-305.
21. Itoh K, Yaoi T, Fushiki S. 2012. Bisphenol A, an endocrine-disrupting chemical, and brain development. Neuropathology 32:447-457.
22. Kunz N, Camm EJ, Somm E, Lodygensky G, Darbre S, Aubert ML, et al. 2011. Developmental and metabolic brain alterations in rats exposed to bisphenol A during gestation and lactation. Int J Dev Neurosci 29:37-43.
23. Lindon JC, Holmes E, Nicholson JK. 2004. Toxicological applications of magnetic resonance. Prog Nucl Magn Reson Spectrosc 45:109-143.
24. Luján R, Shigemoto R, López-Bendito G. 2005. Glutamate and GABA receptor signalling in the developing brain. Neuroscience 130:567-580.
25. Markey CM, Michaelson CL, Veson EC, Sonnenschein C, Soto AM. 2001. The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A. Environ Health Perspect 109:55-60.
26. Martin JC, Canlet C, Delplanque B, Agnani G, Lairon D, Gottardi G, etal. 2009. 1H NMR metabonomics can differentiate the early atherogenic effect of dairy products in hyperlipidemic hamsters. Atherosclerosis 206:127-133.
27. McCombie G, Browning LM, Titman CM, Song M, Shockcor J, Jebb SA, etal. 2009. Omega-3 oil intake during weight loss in obese women results in remodelling of plasma triglyceride and fatty acids. Metabolomics 5:363-374.
28. Nicholson JK, Lindon JC. 2008. Systems biology: metabonomics. Nature 455:1054-1056.
29. Quintás G, Portillo N, García-Cañaveras JC, Castell JV, FerrerA, Lahoz A. 2012. Chemometric approaches to improve PLSDA model outcome for predicting human non-alcoholic fatty liver disease using UPLC-MS as a metabolic profiling tool. Metabolomics 8:86-98.
30. Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, TalsnessCE, etal. 2007. Invivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 24:199-224.
31. Rubin BS, Lenkowski JR, Schaeberle CM, Vandenberg LN, RonsheimPM, Soto AM. 2006. Evidence of altered brain sexual differentiation in mice exposed perinatally to low, environmentally relevant levels of bisphenol A. Endocrinology 147:3681-3691.
32. Rubin BS, Soto AM. 2009. Bisphenol A: perinatal exposure and body weight. Mol Cell Endocrinol 304:55-62.
33. Ryan KK, Haller AM, Sorrell JE, Woods SC, Jandacek RJ, SeeleyRJ. 2010. Perinatal exposure to bisphenol-A and the development of metabolic syndrome in CD-1 mice. Endocrinology 151:2603-2612.
34. Salian S, Doshi T, Vanage G. 2011. Perinatal exposure of rats to bisphenol A affects fertility of male offspring-an overview. Reprod Toxicol 31:359-362.
35. Somm E, Schwitzgebel VM, Toulotte A, Cederroth CR, CombescureC, Nef S, etal. 2009. Perinatal exposure to bisphenol A alters early adipogenesis in the rat. Environ Health Perspect 117:1549-1555.
36. Soto AM, Lin TM, Justicia H, Silvia RM, Sonnenschein C. 1992. An "in culture" bioassay to assess the estrogenicity of xenobiotics. In: Chemically Induced Alterations in Sexual Development: the Wildlife/Human Connection (ColbornT, ClementC, eds). Princeton, NJ:Princeton Scientific Publishing, 295-309.
37. Sumner S, Snyder R, Burgess J, Myers C, Tyl R, Sloan C, etal. 2009. Metabolomics in the assessment of chemical-induced reproductive and developmental outcomes using non-invasive biological fluids: application to the study of butylbenzyl phthalate. J Appl Toxicol 29:703-714.
38. Sun Y, Irie M, Kishikawa N, Wada M, Kuroda N, Nakashima K. 2004. Determination of bisphenol A in human breast milk by HPLC with column-switching and fluorescence detection. Biomed Chromatogr 18:501-507.
39. Thomas P, Dong J. 2006. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J Steroid Biochem Mol Biol 102:175-179.
40. U.S. Food and Drug Administration. 2008. Draft Assessment of Bisphenol A for Use in Food Contact Applications. Available: http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-0038b1_01_02_fda%20bpa%20draft%20assessment.pdf [accessed 28February 2013].
41. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, LeeDH, etal. 2012. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 33:378-455.
42. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM. 2009. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 30:75-95.
43. vom Saal FS, Akingbemi BT, Belcher SM, Birnbaum LS, CrainDA, Eriksen M, etal. 2007. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 24:131-138.
44. vom Saal FS, Nagel SC, Coe BL, Angle BM, Taylor JA. 2012. The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol Cel Endocrinol 354:74-84.
45. Wadia PR, Vandenberg LN, Schaeberle CM, Rubin BS, SonnenscheinC, Soto AM. 2007. Perinatal bisphenol A exposure increases estrogen sensitivity of the mammary gland in diverse mouse strains. Environ Health Perspect 115:592-598.
46. Waters NJ, Holmes E, Waterfield CJ, Farrant RD, NicholsonJK. 2002. NMR and pattern recognition studies on liver extracts and intact livers from rats treated with α-naphthylisothiocyanate. Biochem Pharmacol 64:67-77.
47. Welshons WV, Nagel SC, vom Saal FS. 2006. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147:s56-s69.
48. Welshons WV, Rottinghaus GE, Nonneman DJ, Dolan-Timpe M, Ross PF. 1990. A sensitive bioassay for detection of dietary estrogens in animal feeds. J Vet Diagn Invest 2:268-273.
49. Wold S, Antti H, Lindgren F, Öhman J. 1998. Orthogonal signal correction of near-infrared spectra. Chemometr Intell Lab Syst 44:175-185.
50. Wozniak AL, Bulayeva NN, Watson CS. 2005. Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-α-mediated Ca2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ Health Perspect 113:431-439.
51. Wyss MT, Jolivet R, Buck A, Magistretti PJ, Weber B. 2011. In vivo evidence for lactate as a neuronal energy source. J Neurosci 31:7477-7485.
52. Zalko D, Jacques C, Duplan H, Bruel S, Perdu E. 2011. Viable skin efficiently absorbs and metabolizes bisphenol A. Chemosphere 82:424-430.
53. Zalko D, Soto AM, Dolo L, Dorio C, Rathahao E, Debrauwer L, et al. 2003. Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD1 mice. Environ Health Perspect 111:309-319.
54. Zilberter Y, Zilberter T, Bregestovski P. 2010. Neuronal activity invitro and the invivo reality: the role of energy homeostasis. Trends Pharmacol Sci 31:394-401.